Login to Your Account



Financings Roundup


Tuesday, December 11, 2012
• La Jolla Pharmaceutical Co., of San Diego, released $2.9 million in cash to fund operations through an agreement with holders of preferred stock to waive their right to redeem the stock on Jan. 20, 2013.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription